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ABSTRACT
Background: Radiosurgery is defined as the use of high-dose ionizing radiation for precise and total destruction of a 
chosen target, avoiding concomitant or delayed harm to adjacent tissues. The three types of radiations include gamma 
rays (GammaKnife) by Cobalt-60, X8 rays using linear accelerator (LINAC) system, and charged-particles generated 
from synchocyclotron. Recommendations: Based on current evidence, radiosurgery has proven benefits as the treat-
ment of certain brain metastases, vestibular schwannomas, meningiomas, and some skull base tumors. Conclusion: 
This review describes the current recommendations for use of radiosurgery for intracranial pathologies. Radiosurgery is 
a relatively newer modality in the developing country of Pakistan. Much work is needed to increase awareness and 
promote its use as and when indicated.
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INTRODUCTION
The term “radiosurgery” was coined by Prof. Lars Leksell 
from Karolinska Institute in Stockholm, Sweden. He 
defined radiosurgery as the use of a high-dose ionizing 
radiation for precise and total destruction of a chosen 
target, avoiding concomitant or delayed harm to the 
adjacent tissues (1). He also described the use of stereo-
tactic methods to develop the principles of radiosurgery 
in 1951 (2). Since its advent, radiosurgery has come a 
long way to become an indication for treatment of a 
number of intracranial pathologies. One of the types of 
radiations involved in radiosurgery included the gamma 
rays, and was termed Gamma Knife. Gamma knife 
involves placement of a Leksell frame around the head of 
the patient for stereotactic localization of the brain 
lesion. This is followed by closed skull irradiation in a 
single-treatment session. The frame is used to fix the 
head of the patient, as multiple gamma ray beams focus 
at the chosen target. Cobalt-60 is used as the generation 
source (3). Gamma Knife has evolved to become one of 
the indicated treatments for intracranial brain metastasis 
and vascular malformations (4). Another type of ionizing 
beam used for radiosurgery involved 1 the Linear Accel-
erator (LINAC) system to generate high-speed photons, 
which subsequently produce X-rays focused at a desired 
target lesion. The LINAC system avoids the use of fixed 
frame; the patient lies in a steady position while the 
LINAC head moves around to focus the target through 
different arcs (4). The LINAC system has been developed 
further for improved dose planning and dose distribution 
(3, 4). Moreover, since it does not involve a fixed frame 
system, its use is extended to lesions outside the cranial 
cavity (4). Charged-particle radiosurgery involve proton 
beams generated using synchrocyclotrons. Only few of 
these systems are available in United States, lacking 
popularity mostly because of its high installation and 
maintenance costs (4). The objective of this article is to 
discuss the current recommendations for use of radiosur-
geryin intracranial pathologies. We reviewed the latest 
literature to define the indications and relative indications 
for radiosurgery, and identify the cases where radiosur-
gery is not recommended. This article is also the first 
attempt to highlight the current practices of radiosurgery 
in the developing country, Pakistan. We interviewed the 
providers of stereotactic radiosurgery in Pakistan, as well 
as a few physicians at a tertiary care center in Pakistan, 
whofollow the patients before or after radiosurgical treat-
ment for their intracranial diseases.
INDICATIONS
Brain Metastasis
Stereotactic radiosurgery (SRS) has shown survival rates 
comparable to surgical resection followed by whole-brain 
radiotherapy (5). SRS can be used for single or multiple 
brain metastatic (6), for small lesions (less than 3-3.5cm) 
(7), for surgically inaccessible lesions (5, 7), and for radio-
resistent tumors like melanoma and renal cell carci-
noma (5, 6).
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R E V I E W  A R T I C L E
Meningioma
SRS can be used a primary or adjuvant treatment for 
meningiomas that arise within the base of skull and have 
a high-surgical risk (8), SRS can also be used for recur-
rent skull base lesions (9). Better tumor control rates have 
been observed for benign meningiomas (WHOGrade I – 
about 95% at 5 years) as compared to atypical (WHO 
Grade II – 60% at 5 years) ormalignant meningiomas 
(WHO Grade III – 10% at 5 years) (10).
Vestibular 1 Schwannoma (Acoustic Neuromas)
SRS is indicated for solitary vestibular schwannomas 
that are less than 30mm in cisternal diameter. Better 
outcomes are reported in such patients (11). Treatment 
success rates of 78.2% to 86.9% have been calculated 
even after considering 17% to 30% natural growth rate 
of tumors without intervention (12).
Nonvestibular Schwannoma (Nonacoustic Schwan-
noma)
Radiosurgery has shown good outcomes for trigeminal 
(CN V), facial (CN VII) and jugular foramen (CN IX, X, XI) 
schwannomas (13, 14); it can be used as a primary treat-
ment for small to medium sized lesions, and as an 
adjuvant for residual lesions after large tumor resections 
(13-16).
GlomusJugulare
With good tumor control and lesser cranial nerve deficits 
(IX, X, XI) as compared to gross total resection (17, 18), 
stereotactic radiosurgery is indicated for elderly patients, 
for patients with serious medical conditions, and for 
residual or recurrent tumor (19-21).
Arteriovenous Malformations (AVMs)
Stereotactic radiosurgery has shown complete occlusion 
rates of 72-96% with small AVMs (up to 3ml) (22). 
However, there is a notable risk of bleeding during the 
latent period following radiosurgery and before oblitera-
tion of the lesion. Management of larger AVMs continues 
to be challenging, and even though methods like Salvage 
Therapy (ST), Staged Volume Radiosurgery (SVR) and 
Hypofractionated Stereotactic Radiotherapy (HSRT) have 
been used to avoid higher complication rates (22), multi-
modality treatment approach with embolization, micro-
surgery and/or radiosurgery is recommended (23).
RELATIVE INDICATIONS
Pituitary Adenomas
Stereotactic radiosurgery may be used for small secret-
ing pituitary adenomas that fail to respond to medical 
management, and when surgery is contra-indicated (24). 
However, theremay be a delay before remission and/or 
side-effects of hypopituitarism (25). Hypofractionatedste-
reotactic radiosurgery using cyber-knife may be used for 
non-functioning large tumors, to prevent neuroendocrine 
complications and visual pathway defects (26).
Gliomas
Even with significant risk of radiation complications (27, 
28), the use of SRS is implicated in the treatment of 
high-grade gliomas as a boost after external beam radio-
therapy (EBRT), or for small focal recurrences (29). 
However, the evidence is ambiguous and further 
research isneeded in this area (27). For low-grade 
gliomas, SRS may be used as an adjuvant to surgical 
resection for residual or recurrent lesions, or for surgi-
cally inaccessible tumors (27, 30).
Craniopharyngioma
Stereotactic radiosurgery has a role as a primary treat-
ment for small tumors (<3cm) (31), for recurrent 
lesions (31-33), for patients who are not good candidates 
for surgery (31), and for large tumors after surgical 
decompression/ debulking or in the hypofractionated 
form (33-35).
Cavernous Hemangioma
SRS may be used to avoid operative complications of 
excessive bleeding or damage to adjacent structures (36, 
37). SRS may be a primary therapy for small to medium 
sized lesions confirmed on typical imaging (36, 38), or 
follow surgical resection for any residual tumor in cases 
of large hemangiomas (36, 38).
Hemangioblastoma
With a reasonable outcome of treatment, SRS has a role 
in management of small and solid hemangioblastomas 
(39, 40), and those that cannot be resected surgically (39-42).
Chordoma
SRS is implicated in the management of chordomas with 
reasonable local tumor control when used as an adjunct 
to surgical resection, for residual and recurrent lesions 
(43-46).
Chondrosarcoma
Duration of less than 6 months between diagnosis and 
radiosurgery, age greater than 40 years, and single or no 
prior surgical resection are the factors that predict good 
tumor control after stereotactic radiosurgery (19). Noting 
that, SRS may have a role as an adjunct in select 
patients after maximal surgical resection (19, 47, 48).
Trigeminal Neuralgia
Gamma knife radiosurgery has shown poorer pain 
control outcomes as compared to radiofrequency 
ablation or microvascular decompression (49-52). However, 
gamma knife radiosurgery avoids the operative compli-
cations (50-52), and 1 may be used for patients who 
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cannot undergo invasive procedures (50). Other problems 
associated with gamma knife radiosurgery include the 
delayed affect on facial pain and complications of numb-
ness and paresthesia, especially radiosurgery is 
performed multiple times (49, 52).
Movement Disorders (Essential Tremors, 
Parkinson’s Disease, Multiple Sclerosis)
Gamma knife thalamotomy may improve tremors related 
to Parkinson’s disease and essential tremors (53-56). The 
problems associated with this treatment modality involve 
the delay in the clinical effect and the complications of 
sensory or motor impairments or speech difficulties that 
may manifest months after the procedure (57-59).
NOT RECOMMENDED
Brain metastases
Stereotactic radiosurgery is not recommended for 
lesions greater than 3.5-4cm in diameter ofthose asso-
ciated with obstruction of CSF and hydrocephalus (5). 
Moreover, SRS should not be used for patients who 
score less than 70 on KarnofskyPerformance Scale 
(KPS) or have an uncontrolled systemic malignancy (5).
Arteriovenous Malformations (AVMs)
Radiosurgery after embolization of arteriovenous malfor-
mations has not been recommended in the past (60-62). 
However, recent data suggest that embolization before 
gamma knife radiosurgery may be used in some 
selected cases of large AVMs (63).
Meningioma
For lesions presenting with increasing neurological 
deficits, and for large superficial lesions, stereotactic 
radiosurgery has shown poorer outcomes and should not 
be used (8, 9).
Glioma
In case of newly diagnosed glioblastoma, SRS has no 
survival benefit if administered before fractionated radio-
therapy (27).
Hemagioblastoma
SRS is not recommended for asymptomatic lesions (41), 
or those with cystic component (64).
INCONCLUSIVE 1 EVIDENCE (CONTROVERSIAL)
Cavernous Malformation
While, some studies have shown good outcome and 
regression of lesion after radiosurgery (65, 66), other 
studies have highlighted obvious morbidity risks with only 
limited benefits of this treatment modality (67, 68). Overall, 
the use of radiosurgery for cavernous malformation 
remains controversial (66, 69).
Epilepsy
While stereotactic radiosurgery has shown benefits as a 
treatment modality for epilepsy due to focal lesions 
(tumors, arteriovenous malformations or cavernous 
malformations) (70, 71), there is a lack of evidence to 
adequately define its role in treatment of seizures 
secondary to hypothalamic hamartomas or mesial 
temporal lobe epilepsy; varying results of seizure control 
and complications have been reported (70, 72-75). In 
addition, there is a potential risk ofseizures in the initial 
months after radiosurgery, due to a delay in the anti-
epileptic effect afterthis procedure (70, 71, 73, 74).
Movement Disorders (Bradykinesia, dyskinesia, 
rigidity)
Studies have shown varying improvement and complica-
tion outcomes after gamma knife pallidotomy for brad-
ykinesia, dyskinesia and rigidity (57, 76-78). Further studies 
are needed for definitive recommendations (57).
COMPLICATIONS
The complications of stereotactic radiosurgery could be 
of acute or chronic type, and maypresent years after 
the treatment. The risk of complications is dependant 
on the dose and target volume administered. Brain 
edema (79-81) and radiation-induced cerebral necrosis 
(radio-necrosis) (27, 80-83) are well-known complications 
of stereotactic radiosurgery, with a considerable risk of 
injury to the structures nearby (e.g. optic chiasm, facial 
nerve, etc.). Since there is a significant risk of such 
morbid complications, careful planning and administra-
tion of stereotactic radiosurgery is of utmost impor-
tance in any center where it is practiced. Moreover, 
vasculopathic complications such as aneurysm or varix 
formation, stenotic or occlusive vasculopathy, and 




Gamma Knife Radiosurgery first came to Pakistan in May 
2008 at the Neurospinal and Medical Institute at Kara-
chi. It was shortly followed by the first LINAC system 
introduced at the same institute. Since its installation, 
1700 cases of Gamma Knife, and 800 cases using the 
LINAC system have been performed. Majority of the 
procedures include Vestibular Schwannomas, Meningi-
omas, Pituitary Adenomas, Gliomas, and Arteriovenous-
Malformations. Other cases such as Craniopharyngio-
mas, tumors of Pineal region, and Cavernous malforma-
tions have also been treated. Patients are mostly from 
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Sindh (including Karachi), followed by Punjab and 
Khyber Pakhtunkhwa. With the apparent advantage of 
shorter duration of treatment, and faster recovery, 
Gamma Knife is becoming increasingly popular among 
the patients. Nevertheless, its use must be limited to 
treat the pathologies as and when indicated. There is 
significant scope for further growth and development of 
Gamma Knife radiosurgery in Pakistan. Additional 
gamma knife systems, one in each province, would 
make this treatment more accessible for patients, and 
can improve the outcomes of diseases that are other-
wise easily manageable in other parts of the world.
LINAC (CyberKnife) Radiosurgery
LINAC (CyberKnife) system was introduced in Pakistan 
even more recently than Gamma Knife. Patients’ Aid 
Foundation, a non-governmental organization (NGO), 
helped install theCyberKnife system at Jinnah 
Postgraduate Medical Center (JPMC) in Karachi in 
2011. Sinceits installation, 905 sessions have been 
given to 269 patients from all over the country, and 
abroad. The treatment is offered for various lesions in 
the brain and the rest of the body. Majority of the 
patients come from Sindh (including Karachi), followed 
by the rest of the provinces.
The intracranial pathologies for which CyberKnife has 
been used include Vestibular Schwannomas, Meningi-
oma, Brain metastases, Arteriovenous malformations, 
Craniopharyngioma, Pituitary Adenoma, Trigeminal 
Neuralgia, Giant cell tumor, Ependymoma, Glomus 
tumors, and others. Extracranial lesions in the prostate, 
lymph node, liver and spine are also treated with 
CyberKnife Radiosurgery. Initial follow-up results have 
shown good outcomes with the use of CyberKnife. 
However, a longer follow-up would be required for 
substantial conclusions. 9
Room for improvement
Stereotactic radiosurgery in Pakistan is a fairly recent 
treatment modality as compared to its introduction and 
use in the developed parts of the world; there is a signifi-
cant room for improvement in this field to provide better 
healthcare for the patients. Stereotactic radiosurgery 
requires a multi-disciplinary approach to evaluate the 
patient’s disease, and manage it according to the best 
possible evidence. Additional equipment with experi-
enced operators is needed in various cities across the 
country to make this treatment modality more accessi-
ble and improve the quality of care provided by the 
involved healthcare personnel.
Similarly, a good referral system will improve the follow-
up of patients undergoing stereotactic radiosurgery, 
providing a means to monitor and utilize Gamma Knife 
and CyberKnife as one of the treatment options for 
indicated lesions.
CONCLUSION
With the advancement in neuro-imaging, stereotactic 
technology, and robotics, radiosurgery has become one 
of the key modalities in treatment of various intracranial 
pathologies. This review describes the current recom-
mendations based on the most recent literature. With 
the ongoing research to make tumor cells more radio-
sensitive and healthy cells more radioresistent, 
additional applications of radiosurgery can be antici-
pated. Nevertheless,stereotactic radiosurgery is not free 
from complications; it is very important to carefully 
evaluate individual cases in a multi-disciplinary setting 
before using stereotactic radiosurgeryas a treatment 
modality, and administer the radiation in a strictly 
controlled fashion.
Concurrently, as compared to the developed parts of the 
world, radiosurgery is relatively a new concept in a devel-
oping country like Pakistan; there have been only less 
than 6 years of experience in Gamma Knife, and 2 years 
of experience in CyberKnife procedures. There is a dire 
need to spread awareness and form a good referral 
system, so patients can benefit from radiosurgery as and 
when indicated. Moreover, additional equipment is 
needed to make thistreatment more accessible for 
patients and improve the outcomes of otherwise man-
ageable diseases.
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